Clinical Trial for Effectiveness and Safety Evaluation of Hemodiafilter

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 160 participants.

Also called NCT06454981

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 160 participants (enrolled count) (from the registry)
Sponsor
Hangzhou Kaiyuan Suixi Medical Technology Co., Ltd (from the registry)
Registry
  • NCT NCT06454981
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06454981. Randomized; no masking; primary purpose treatment. Start 2021-07-23 (actual); primary completion 2021-11-02 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Trial for Effectiveness and Safety Evaluation of Hemodiafilter
Condition
Renal Failure Chronic
Intervention (Device)
Hemodiafilter
Intervention (Device)
Fresenius Medical Care AG & Co.KGaA
Lead sponsor
Hangzhou Kaiyuan Suixi Medical Technology Co., Ltd (class: other)

Record details

Record id
cardio:ct-nct06454981
Content hash
8799749d704e272970abe7ec609f7bf29693a8d3df0bf58d6b81fe1a39cf021d